Search

Your search keyword '"De Donato G"' showing total 26 results
Start Over Author "De Donato G" Publisher elsevier bv
26 results on '"De Donato G"'

3. A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stenting

Author

de Vries, Evelien E., primary, Meershoek, Armelle J.A., additional, Vonken, Evert J., additional, den Ruijter, Hester M., additional, van den Berg, Jos C., additional, de Borst, Gert J., additional, Bijuklic, K., additional, Schofer, J., additional, Bonati, L., additional, Bosiers, M., additional, Wauters, J., additional, de Donato, G., additional, Chisci, E., additional, Setacci, C., additional, Doig, D., additional, Featherstone, R.L., additional, Dobson, J., additional, Brown, M.M., additional, Eskandari, M.K., additional, Giri, J., additional, Grunwald, I.Q., additional, Kühn, A.L., additional, Han, D.K., additional, Faries, P.L., additional, Hernandez-Fernandez, F., additional, Parrilla, G., additional, Hornung, M., additional, Sievert, H., additional, Kono, K., additional, Latacz, P., additional, Ledwoch, J., additional, Mudra, H., additional, Maleux, G., additional, Nolz, R., additional, Ohki, T., additional, Piazza, M., additional, Pieniazek, P., additional, Tekieli, L., additional, Radak, D., additional, Tanaskovic, S., additional, Rasiova, M., additional, Simonte, G., additional, Fiorucci, B., additional, Tietke, M.W.K., additional, and Ventoruzzo, G., additional

Published
2019
Full Text
View/download PDF

4. Acute Limb Ischemia in Elderly Patients: Can Iloprost be Useful as an Adjuvant to Surgery? Results from the ILAILL Study

Author

de Donato, G., primary, Gussoni, G., additional, de Donato, G., additional, Cao, P., additional, Setacci, C., additional, Pratesi, C., additional, Mazzone, A., additional, Ferrari, M., additional, Veglia, F., additional, Bonizzoni, E., additional, Settembrini, P., additional, Ebner, H., additional, Martino, A., additional, and Palombo, D., additional

Published
2007
Full Text
View/download PDF

10. Chapter III: Management of Cardiovascular Risk Factors and Medical Therapy

Author

Diehm, N., primary, Schmidli, J., additional, Setacci, C., additional, Ricco, J.-B., additional, de Donato, G., additional, Becker, F., additional, Robert-Ebadi, H., additional, Cao, P., additional, Eckstein, H.H., additional, De Rango, P., additional, Teraa, M., additional, Moll, F.L., additional, Dick, F., additional, Davies, A.H., additional, Lepäntalo, M., additional, and Apelqvist, J., additional

Published
2011
Full Text
View/download PDF

11. Chapter I: Definitions, Epidemiology, Clinical Presentation and Prognosis

Author

Becker, F., primary, Robert-Ebadi, H., additional, Ricco, J.-B., additional, Setacci, C., additional, Cao, P., additional, de Donato, G., additional, Eckstein, H.H., additional, De Rango, P., additional, Diehm, N., additional, Schmidli, J., additional, Teraa, M., additional, Moll, F.L., additional, Dick, F., additional, Davies, A.H., additional, Lepäntalo, M., additional, and Apelqvist, J., additional

Published
2011
Full Text
View/download PDF

12. Chapter VI: Follow-up after Revascularisation

Author

Dick, F., primary, Ricco, J.-B., additional, Davies, A.H., additional, Cao, P., additional, Setacci, C., additional, de Donato, G., additional, Becker, F., additional, Robert-Ebadi, H., additional, Eckstein, H.H., additional, De Rango, P., additional, Diehm, N., additional, Schmidli, J., additional, Teraa, M., additional, Moll, F.L., additional, Lepäntalo, M., additional, and Apelqvist, J., additional

Published
2011
Full Text
View/download PDF

13. Chapter V: Diabetic Foot

Author

Lepäntalo, M., primary, Apelqvist, J., additional, Setacci, C., additional, Ricco, J.-B., additional, de Donato, G., additional, Becker, F., additional, Robert-Ebadi, H., additional, Cao, P., additional, Eckstein, H.H., additional, De Rango, P., additional, Diehm, N., additional, Schmidli, J., additional, Teraa, M., additional, Moll, F.L., additional, Dick, F., additional, and Davies, A.H., additional

Published
2011
Full Text
View/download PDF

14. Chapter II: Diagnostic Methods

Author

Cao, P., primary, Eckstein, H.H., additional, De Rango, P., additional, Setacci, C., additional, Ricco, J.-B., additional, de Donato, G., additional, Becker, F., additional, Robert-Ebadi, H., additional, Diehm, N., additional, Schmidli, J., additional, Teraa, M., additional, Moll, F.L., additional, Dick, F., additional, Davies, A.H., additional, Lepäntalo, M., additional, and Apelqvist, J., additional

Published
2011
Full Text
View/download PDF

15. Chapter IV: Treatment of Critical Limb Ischaemia

Author

Setacci, C., primary, de Donato, G., additional, Teraa, M., additional, Moll, F.L., additional, Ricco, J.-B., additional, Becker, F., additional, Robert-Ebadi, H., additional, Cao, P., additional, Eckstein, H.H., additional, De Rango, P., additional, Diehm, N., additional, Schmidli, J., additional, Dick, F., additional, Davies, A.H., additional, Lepäntalo, M., additional, and Apelqvist, J., additional

Published
2011
Full Text
View/download PDF

16. Proteomic analysis of atherosclerotic plaque

Author

Porcelli, B., primary, Ciari, I., additional, Felici, C., additional, Pagani, R., additional, Banfi, C., additional, Brioschi, M., additional, Giubbolini, M., additional, de Donato, G., additional, Setacci, C., additional, and Terzuoli, L., additional

Published
2010
Full Text
View/download PDF

24. Managing Peripheral Artery Disease in Diabetic Patients: A Questionnaire Survey from Vascular Centers of the Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS)

Author

G Bajardi, Francesco Setacci, Emad Hussein, Giancarlo Bracale, Olivier Goëau-Brissonnière, Ben R. Saleem, E Dinoto, Liborio Ferrante, Jamal J. Hoballah, Gianmarco de Donato, Maurizio Taurino, Bruno Gossetti, F Pecoraro, Bianca Pane, Anna Giribono, Raffaele Pulli, Vincenzo De Luca, Tarek Sraieb, Carlo Setacci, Andrea Stella, Umberto Bracale, Matteo Tozzi, Raffaele Pio Ammollo, Mohamed N. Bouayed, Patrizio Castelli, Maddalena Illario, Bracale U.M., Ammollo R.P., Hussein E.A., Hoballah J.J., Goeau-Brissonniere O., Taurino M., Setacci C., Pecoraro F., Bracale G., Giribono A.M., Ferrante L., de Donato G., Dinoto E., Bajardi G., Illario M., Bouayed M.N., Saleem B.R., Pulli R., Gossetti B., Pane B., Castelli P., Tozzi M., Sraieb T., Setacci F., Stella A., De Luca V., Bracale, Umberto Marcello, Ammollo, Raffaele Pio, Hussein, Emad A, Hoballah, Jamal J, Goeau-Brissonniere, Olivier, Taurino, Maurizio, Setacci, Carlo, Pecoraro, Felice, and Bracale, Giancarlo

Subjects
medicine.medical_treatment, Psychological intervention, 030204 cardiovascular system & hematology, vascular surgery, Settore MED/22 - Chirurgia Vascolare, 030218 nuclear medicine & medical imaging, Wound care, 0302 clinical medicine, Ischemia, Practice Patterns, Physicians', Response rate (survey), Practice Patterns, Nurses', diabetes, Mediterranean Region, Endovascular Procedures, vascular medicine, General Medicine, Treatment Outcome, Cardiology and Cardiovascular Medicine, Vascular Surgical Procedures, diabetic foot, management, Specialization, Reoperation, medicine.medical_specialty, Revascularization, Nurse's Role, Amputation, Surgical, 03 medical and health sciences, peripheral arterial disease, Mediterranean Sea, medicine, Humans, Training, Healthcare Disparities, Endovascular Surgery, Vascular Surgery, Physician's Role, Patient Care Team, Wound Healing, business.industry, General surgery, Vascular surgery, medicine.disease, Diabetic foot, Amputation, Health Care Surveys, Orthopedic surgery, Surgery, business, wound care
Abstract

Background The Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS) was founded on October 1, 2018, to enhance cooperation among vascular professionals within Mediterranean countries. Due to its prominent social and economic impact on national health systems, diabetic arteriopathy has been selected as the very first topic to be investigated by the federation. Methods MeFAVS members were asked to reply to a questionnaire on the management of diabetic ischemic foot. Results were collected and analyzed statistically. The questionnaire consisted of 15 multiple choice answers regarding diabetic foot (DF) diagnosis and treatment. The questionnaire was submitted to 21 centers on April 20, 2019. Results Response rate was 62%. The survey revealed that vascular surgeons, diabetologists, and wound care nurses made-up the core of the diabetic teams present in 76.9%, 69.3%, and 92.3% of the centers, respectively. Diabetic teams were most often led by vascular surgeons (53.8%) and diabetologists (42.2%), but only in 7.9% of cases by nurses. Duplex ultrasonography and computed tomographic angiography were the most commonly available tools used to assess diabetic peripheral arterial disease (PAD). Surgical wound care was undertaken by vascular surgeons in the majority of cases, and only in 46.2% of the cases to orthopedic or plastic surgeons, while nonsurgical wound care was handled by specialized nurses (76.6%) and diabetologists (53.8%). First-line revascularization was preferred over conservative treatment (61.5% vs 53.8%) and endovascular strategy (45.3%) over open (33.7%) or hybrid (21.0%) surgery. Vascular surgeons and interventional radiologists were found to be the most common performers of endovascular revascularization (92.3% and 53.8%, respectively). Amputations had an overall rate of 16.6% (range 4–30%) and a mean reintervention rate of 22.5%, and were usually performed by vascular surgeons for both minor and major interventions (84.6%) followed by orthopedic surgeons (15.4% minor and 30.8% major). The availability of a DF clinic (84.6%) and endovascular (53.8%) and open surgery (46.2%) capabilities were considered fundamental to reduce amputation rates. Conclusions Especially since the introduction and spreading of new endovascular techniques for the treatment of DF, it is a common consensus amongst vascular surgeons that a standardized approach to the discipline is necessary in order to improve outcomes such as amputation-free survival and mortality and it is with this perspective and purpose that transnational cooperation amongst vascular professionals and residents in training are aiming for greater proficiency in endovascular and open surgery.

Published
2020

25. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease

Author

Alessandro De Stefano, Antonio Caruso, Giuseppe De Donato, Abdelkader Taibah, Mario Sanna, Francesco Dispenza, De Stefano A., Dispenza F., De Donato G., Caruso A., Taibah A., and Sanna M.

Subjects
inner ear, Adult, Male, medicine.medical_specialty, Tympanic Membrane, gentamicin, Injections, Intratympanic gentamicin, vertigo, Audiometry, Quality of life, Vertigo, medicine, Humans, Meniere Disease, Aged, Retrospective Studies, Antibacterial agent, biology, business.industry, Aminoglycoside, Middle Aged, medicine.disease, biology.organism_classification, Anti-Bacterial Agents, Surgery, Treatment Outcome, Otorhinolaryngology, Poor control, Female, Gentamicin, Gentamicins, business, Meniere's disease, medicine.drug
Abstract

Purpose The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere's disease (MD). Materials and Methods We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology–Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), good control in 16% (class B), moderate control in 4% (class C), poor control in 16% (class D), and no control in 4% (class E) of the patients. Audiological assessment showed unchanged thresholds in 61%, improvement in 22%, and worsening in 17% of the cases. Conclusion Administration of gentamicin is a good alternative to medical and surgical procedures in the treatment of intractable MD. One-day treatment allows for adequate control of vertigo attacks without compromising hearing and quality of life and with reduced costs.

Published
2007

26. Chronic otitis caused by heterotopic brain tissue in pterygopalatine fossa

Author

Alessandro De Stefano, Giuseppe De Donato, Enrico Piccirillo, Gautham Kulamarva, Francesco Dispenza, DE DONATO G, DE STEFANO A, DISPENZA F, KULAMARVA G, and PICCIRILLO E

Subjects
Heterotopic brain tissue, business.industry, Chronic otitis, Brain tissue, Anatomy, medicine.disease, Conductive hearing loss, Parapharyngeal space, medicine.anatomical_structure, Otorhinolaryngology, Nasal region, Pediatrics, Perinatology and Child Health, medicine, Cranial cavity, Spinal canal, business, Glue ear, Pterygopalatine fossa
Abstract

Summary Heterotopic brain tissue is a rare is congenital anomaly, it may present at any age but it is frequently in infancy. This anomaly can occur most frequently in nasal region, although rests elsewhere in the digestive tract, in facial tissue or in lungs have been reported. Heterotopic brain tissue has been defined as a mass composed of mature brain tissue, outside the cranial cavity or spinal canal. We present a 9 years old girl with history of left chronic otitis and nasal obstruction caused by heterotopic brain tissue in pterygopalatine fossa.

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results